Scientists test Needle-Free COVID booster as nasal spray
NCT ID NCT06441968
Summary
This early-stage study tested the safety and immune response of a new nasal spray COVID-19 booster vaccine called MPV/S-2P. It involved 60 healthy adults who had already received their primary mRNA COVID-19 vaccines and at least one booster shot. Researchers gave participants the nasal spray vaccine and monitored them for side effects while measuring antibody levels in their blood and nasal passages.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030-3411, United States
-
NYU Grossman Long Island School of Medicine - Vaccine Center
Mineola, New York, 11501, United States
-
The Hope Clinic of Emory University
Decatur, Georgia, 30030-1705, United States
Conditions
Explore the condition pages connected to this study.